TD Cowen Has Lowered Expectations for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price target lowered by analysts at TD Cowen from $660.00 to $585.00 in a note issued to investors on Wednesday,MarketScreener reports. The firm presently has a “buy” rating on the medical equipment provider’s stock. TD Cowen’s price target indicates a potential upside of 22.18% from the company’s previous close.

A number of other research analysts have also commented on ISRG. Raymond James Financial upped their price objective on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Argus reduced their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. UBS Group reduced their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a report on Tuesday, March 17th. Finally, Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday, January 26th. Eighteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $581.91.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $478.82 on Wednesday. The company has a 50-day simple moving average of $477.54 and a 200-day simple moving average of $515.16. The firm has a market capitalization of $170.04 billion, a P/E ratio of 58.04, a P/E/G ratio of 3.78 and a beta of 1.68. Intuitive Surgical has a 52 week low of $427.84 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.81 earnings per share. As a group, equities analysts forecast that Intuitive Surgical will post 8.16 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other news, Director Gary S. Guthart sold 24,500 shares of the business’s stock in a transaction on Tuesday, January 27th. The shares were sold at an average price of $530.10, for a total value of $12,987,450.00. Following the sale, the director owned 3,694 shares in the company, valued at approximately $1,958,189.40. The trade was a 86.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the sale, the executive vice president owned 409 shares in the company, valued at $202,438.64. This represents a 50.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 32,943 shares of company stock worth $17,279,568 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Intuitive Surgical by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after purchasing an additional 263,828 shares in the last quarter. State Street Corp boosted its stake in shares of Intuitive Surgical by 1.0% in the 4th quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock valued at $8,892,753,000 after purchasing an additional 162,264 shares in the last quarter. Capital World Investors boosted its stake in shares of Intuitive Surgical by 1.7% in the 4th quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock valued at $4,449,491,000 after purchasing an additional 127,526 shares in the last quarter. Norges Bank acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at $2,856,987,000. Finally, Invesco Ltd. boosted its stake in shares of Intuitive Surgical by 17.4% in the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after purchasing an additional 611,268 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 beat and raised outlook — ISRG reported stronger‑than‑expected Q1 revenue and EPS, raised full‑year procedure guidance and cited broad procedure adoption; that drove the initial rally after the print. Read More.
• Positive Sentiment: da Vinci 5 and innovation-led revenue — Analysts and coverage note revenues are outpacing procedures as da Vinci 5 placements and service/consumable pricing power shift growth toward innovation and value-based revenue. Read More.
• Positive Sentiment: Analysts reaffirm bullish views — several firms reiterated buy/overweight ratings and raised forecasts after the quarter, saying procedure momentum and platform adoption support longer‑term upside. Read More.
• Neutral Sentiment: Market commentary highlights long‑term case — investment pieces argue ISRG remains a secular winner in robotic surgery despite near‑term volatility; these are thematic views rather than short‑term catalysts. Read More.
• Negative Sentiment: Mixed/trimmed price targets — several banks trimmed price targets post‑earnings (some materially) even while keeping buy/overweight ratings; the patchwork of cuts likely contributed to selling pressure. Read More.
• Negative Sentiment: Cybersecurity note — the company disclosed a contained cyber incident and is remediating; while management calls it contained, such disclosures can increase near‑term uncertainty for investors. Read More.
• Negative Sentiment: Guidance conservatism / profit‑taking — some coverage points out the company raised guidance modestly relative to the beat, which may signal conservative assumptions and prompted traders to book gains after the initial surge. Read More.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.